Adam Shultz Adler

7 Patents

• US125903862026

  Recombinant Polyclonal Proteins and Methods of Use Thereof

  Gigagen, Inc.

  0 cites
• US124977112025

  Engineered Cells Expressing Anti-viral T Cell Receptors and Methods of Use Thereof

  Gigamune, Inc.

  0 cites
• US124213112025

  Anti-ctla-4 Binding Proteins and Methods of Use Thereof

  Gigagen, Inc.

  0 cites
• US124046072025

  Recombinant Polyclonal Proteins Targeting COVID-19 and Methods of Use Thereof

  Gigagen, Inc.

  0 cites
• US121958802025

  Systems and Methods for Massively Parallel Combinatorial Analysis of Single Cells

  Gigagen, Inc.

  0 cites
• US117186602023

  Recombinant Polyclonal Proteins Targeting Zika and Methods of Use Thereof

  Gigagen, Inc.

  0 cites
• US116857792023

  Recombinant Polyclonal Proteins Targeting COVID-19 and Methods of Use Thereof

  Gigagen, Inc.

  0 cites